11:12 :
Vectura rises after swinging to first-half profit -
Biotech reports progress on asthma and smoker's cough drugsVectura, which specialises in drugs for respiratory diseases such as asthma and chronic obstructive pulmonary (COPD) disease, enjoyed a 5% bounce in its share price after swinging to a first-half ...